直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

The Seventh Amendment Does Not Bar Pre-Verdict Supplemental Damages

March 9, 2021

Authored and Edited by Shannon M. Patrick; Kara A. Specht; Elizabeth D. Ferrill

In Bayer Healthcare LLC v. Baxalta Inc., No. 19-2418 (Fed. Cir. Mar. 1, 2021), the Federal Circuit reviewed many issues on appeal, including Baxalta’s Seventh Amendment challenge.

Baxalta argued that the district court violated the company’s Seventh Amendment right to a jury trial by awarding Bayer pre-verdict supplemental damages. The jury calculated damages between June 14, 2016 and November 30, 2018. The district court then awarded Bayer pre-verdict supplemental damages for the period between December 1, 2018 and the date the judgment was entered, February 8, 2019.

The Federal Circuit upheld the pre-verdict supplemental damages award. Although the Court noted that an additur would violate the Seventh Amendment, it found that the district court’s award was a proper damages award under 35 U.S.C. § 284, which gives the district court the ability to assess damages for the claimant that were not found by the jury. In awarding damages, the district court merely applied “the jury’s royalty rate to the undisputed actual infringing sales base” to calculate the damages. Slip op. at 32. Therefore, the district court’s pre-verdict damages award did not constitute “an impermissible additur or an otherwise ‘bald addition of something which in no sense can be said to be included in the verdict.’” Id. at 33.

 

Tags

damages

For more information

  • Bayer Healthcare LLC v. Baxalta Inc.

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Related Industries

Life Sciences

Pharmaceutical

Related Offices

Atlanta, GA

Washington, DC

Contacts

Shannon M. Patrick
Associate
Atlanta, GA
+1 404 653 6558
Email
Kara A. Specht
Partner
Atlanta, GA
+1 404 653 6481
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

IAM Live: Navigating the UPC 2026

November 4, 2026

Paris

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Lecture

2026 Donald R. Dunner Endowed Lecture

October 27, 2026

Washington, DC

Conference

2026 FCBA Global Series Fall Session

October 14-16, 2026

Dublin

Seminar

PTAB Bar Association Thought Leader Summit 2026

October 7, 2026

Alexandria

Reception

Congress 2026: Durable Strategy, Enduring Value – Sustainable IP

September 14, 2026

Manchester

Articles

California Brings First CCPA and Delete Act Enforcement Action Against Data Broker

September 4, 2026

European IP Blog

The Decision in G 1/25: A More Relaxed Approach to Description Amendments in Europe?

3 September 2026

Articles

D. Mass. Patent Litigation Update: July 2026

August 27, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP